Lithium Versus Anticonvulsants and the Risk of Physical Disorders - Trial NCT06005155
Access comprehensive clinical trial information for NCT06005155 through Pure Global AI's free database. This phase not specified trial is sponsored by Mental Health Services in the Capital Region, Denmark and is currently Completed. The study focuses on Bipolar Disorder. Target enrollment is 169285 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Mental Health Services in the Capital Region, Denmark
Timeline & Enrollment
N/A
Jun 01, 2022
Jul 01, 2023
Primary Outcome
Incident stroke (separately for intracerebral hemorrhage and cerebral infarction),Arteriosclerosis,Angina pectoris,Myocardial infarction,Diabetes mellitus (separately for type 1 diabetes and type 2 diabetes),Myxoedema,Osteoporosis,Dementia (separately for Alzheimer's disease and other dementia),Parkinson's disease,Chronic kidney disease (definite chronic kidney disease and possible Chronic kidney disease)
Summary
Nationwide population-based register linkage study covering the entire 5.9 million
 inhabitants in Denmark systematically investigating the associations between sustained
 long-term use of lithium versus lamotrigine and valproate, and the risk of a range of
 physical disorders emulating a randomized trial.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06005155
Non-Device Trial